Axa boosted its position in shares of Stryker Corporation (NYSE:SYK) by 6.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 516,156 shares of the medical technology company’s stock after acquiring an additional 31,375 shares during the period. Axa owned approximately 0.14% of Stryker worth $73,304,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Renaissance Technologies LLC acquired a new stake in Stryker during the first quarter valued at approximately $948,000. Xact Kapitalforvaltning AB boosted its holdings in Stryker by 0.8% during the second quarter. Xact Kapitalforvaltning AB now owns 52,681 shares of the medical technology company’s stock valued at $7,311,000 after purchasing an additional 427 shares in the last quarter. Stock Yards Bank & Trust Co. acquired a new stake in Stryker during the second quarter valued at approximately $212,000. Atria Investments LLC boosted its holdings in Stryker by 9.7% during the second quarter. Atria Investments LLC now owns 6,815 shares of the medical technology company’s stock valued at $946,000 after purchasing an additional 604 shares in the last quarter. Finally, Private Trust Co. NA boosted its holdings in Stryker by 1.8% during the second quarter. Private Trust Co. NA now owns 23,506 shares of the medical technology company’s stock valued at $3,262,000 after purchasing an additional 418 shares in the last quarter. Hedge funds and other institutional investors own 74.97% of the company’s stock.
A number of equities research analysts have weighed in on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker in a report on Thursday, December 7th. Royal Bank of Canada reaffirmed a “buy” rating and set a $155.00 price objective on shares of Stryker in a report on Monday, October 2nd. BidaskClub raised Stryker from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. BMO Capital Markets raised Stryker to a “market perform” rating and set a $163.00 price objective on the stock in a report on Tuesday. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $161.00 price objective on shares of Stryker in a report on Monday, October 2nd. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $153.19.
Stryker Corporation (NYSE:SYK) traded down $1.97 during trading hours on Friday, reaching $151.34. The company’s stock had a trading volume of 1,406,700 shares, compared to its average volume of 1,178,710. Stryker Corporation has a 12-month low of $116.50 and a 12-month high of $160.62. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.61 and a current ratio of 2.37. The firm has a market cap of $57,374.37, a P/E ratio of 24.30, a price-to-earnings-growth ratio of 2.41 and a beta of 0.78.
Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.50 by $0.02. Stryker had a return on equity of 24.11% and a net margin of 14.67%. The firm had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter in the prior year, the business earned $1.39 EPS. The business’s revenue for the quarter was up 6.1% compared to the same quarter last year. analysts forecast that Stryker Corporation will post 6.47 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Shareholders of record on Friday, December 29th will be issued a dividend of $0.47 per share. This is an increase from Stryker’s previous quarterly dividend of $0.43. The ex-dividend date is Thursday, December 28th. This represents a $1.88 annualized dividend and a yield of 1.24%. Stryker’s dividend payout ratio is currently 36.32%.
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
What are top analysts saying about Stryker? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stryker and related companies.